Insight Partners-backed GraphPad Software, a privately held California software firm, completed the acquisition of SnapGene, a bioinformatics software solution. Financial terms were not disclosed. "We are honored to welcome SnapGene into our growing portfolio. The company has already had a phenomenal impact advancing research at leading institutions and biotech and pharmaceutical companies. We look forward to empowering even more scientists with this technology, and further serving and supporting the global scientific community," Thomas Swalla, GraphPad Software CEO.